Phialogics (private company)

See something wrong or missing? Let us know
Offices:Basel
Business model:B2B

Phialogics is a Swiss preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 659k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Phialogics

Name Criteria
Sweden Molecular Attraction
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Finland StemSight
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Phase Biolabs
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Videm
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Thytech
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Spain AtG Therapeutics
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Italy Diamante
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Spain InnoUp Farma
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Merozyne Therapeutics
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Next Tip
45%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: < 1M USD
Top